AMA1-C1/alhydrogel Malaria Vaccine

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

MalariaPlasmodium Falciparum Malaria

Phase 1

Experimental Vaccine for Malaria in Adults in Mali

CompletedNCT00343005

National Institute of Allergy and Infectious Diseases (NIAID)Plasmodium Falciparum Malaria

Start: 2004-04-23End: 2008-01-22Target: 54Updated: 2017-07-02

Malaria Vaccine in Children in Mali

CompletedNCT00341250

National Institute of Allergy and Infectious Diseases (NIAID)Malaria

Start: 2006-01-19End: 2006-12-08Target: 900Updated: 2017-07-02

Related Papers

Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria.

2008-08-1385 citations

Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children.

2008-02-1338 citations

Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians.

2007-10-1749 citations